Are your PBM pricing discounts seriously underperforming?
By Chris Hanson-EhlingerMon, Apr, 07, 2014
Pricing guarantees are tricky. Even with a traditional arrangement (locked-in brand discounts and dispensing fees) you still have to account for generic pricing and aggregated guarantees often can’t be calculated until the end of the year. Measuring generic effective rates in the middle of a pricing term is difficult, too, and your PBM may argue that any sign of underperformance is not a cause for concern because the term is incomplete.
- CMS Issues New Proposed Protocols for Medicare Part C and D Program Audits and Part C Timeliness Monitoring Project. Proposed Changes Would Take Effect in 2021 Audit Year.
- How PBMs Make Money in the Medicare Part D Market – A GAO Report Analysis
- PBM Impact from COVID-19
- What Health Plans Need to Know about Medicaid Encounter Data
- Preparing Your Health Plan for 2020: A CMS Program Audit Checklist